Abstract
Background: 3D tumors express different adhesion receptors from those expressed in monolayers, leading to a distinct microenvironment. The third dimension also brings mass transport into relevance, as inadequate diffusion of oxygen produces hypoxia. This study investigates the effects of distinct 3D environments on hypoxia-associated apoptosis and drug resistance. Materials and Methods: Under hypoxia and normoxia, U251 glioma cells and U87 astrocytoma cells were grown as spheroids on flat substrates, scaffolds seeded with dispersed cells, and spheroid-seeded scaffolds. The samples were subsequently treated with doxorubicin and resveratrol, known inducers of apoptosis. Results: All 3D environments induced increased but distinct resistance to apoptosis, as evident by lower caspase-3 activity, and higher production of anti-apoptotic proteins BCL-2 and survivin. Hypoxic monolayers also exhibited higher resistance to doxorubicin and higher production of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), but lower production of BCL-2 and survivin. Conclusion: These findings suggest that in vitro, 3D models acquire greater apoptosis resistance via up-regulation of anti-apoptotic proteins, and that the precise mechanism depends on the individual 3D microenvironment.
Original language | English (US) |
---|---|
Pages (from-to) | 3237-3245 |
Number of pages | 9 |
Journal | Anticancer research |
Volume | 31 |
Issue number | 10 |
State | Published - Oct 2011 |
Externally published | Yes |
Keywords
- Anticancer drug and apoptosis
- Anticancer drug resistance
- Cell-to-cell interaction/adhesion molecules
- Characteristics of cancer cells
- Chemotherapy
- Drug sensitivity/drug resistance-relating factors/gene expression analysis
- Evaluation and prediction of pharmacological effects
- Screening systems
ASJC Scopus subject areas
- Oncology
- Cancer Research